CD1D and colitis: Our study revealed that DSS-induced colitis led to the decline of ZO-1 and occludin levels, anti-inflammatory cytokine levels, and number of CD1d+ B cells, while increased the proinflammatory cytokine levels, number of CD138+ B cells, and DNA methylation level, which were consistent with the previous studies [43–45].